We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$116M
AUM Growth
-$1.44M
Cap. Flow
-$1.6M
Cap. Flow %
-1.38%
Top 10 Hldgs %
24.2%
Holding
184
New
25
Increased
26
Reduced
81
Closed
25

Top Buys

Rank Stock Value
1
VLO icon
Valero Energy
VLO
+$1.1M
2
AZN icon
AstraZeneca
AZN
+$748K
3
NVS icon
Novartis
NVS
+$704K
4
AVT icon
Avnet
AVT
+$701K
5
SYNA icon
Synaptics
SYNA
+$698K

Sector Composition

Rank Sector Weight
1 Healthcare 19.02%
2 Industrials 16.07%
3 Consumer Staples 15.08%
4 Financials 12.64%
5 Consumer Discretionary 12.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSX icon
101
Phillips 66
PSX
$81.9B
$413K 0.36%
+5,200
New +$425K
GAP
102
The Gap Inc
GAP
$7.41B
$401K 0.35%
18,900
-650
-3% -$13.8K
REGN icon
103
Regeneron Pharmaceuticals
REGN
$80.1B
$400K 0.34%
1,145
+170
+17% +$65.5K
DVA icon
104
DaVita
DVA
$11.5B
$392K 0.34%
5,075
-3,250
-39% -$246K
GOOGL icon
105
Alphabet (Google) Class A
GOOGL
$4.36T
$390K 0.34%
+11,100
New +$407K
WHR icon
106
Whirlpool
WHR
$2.87B
$387K 0.33%
2,325
-400
-15% -$70.6K
GD icon
107
General Dynamics
GD
$105B
$383K 0.33%
2,750
+550
+25% +$76.7K
SAVE
108
DELISTED
Spirit Airlines, Inc.
SAVE
$376K 0.32%
8,375
-1,450
-15% -$64.5K
SWKS icon
109
Skyworks Solutions
SWKS
$10.4B
$373K 0.32%
5,900
BDC icon
110
Belden
BDC
$5.09B
$370K 0.32%
6,125
-225
-4% -$14.1K
QSR icon
111
Restaurant Brands International
QSR
$25.6B
$364K 0.31%
8,761
AJG icon
112
Arthur J. Gallagher & Co
AJG
$64.1B
$362K 0.31%
7,600
-3,100
-29% -$144K
ALK icon
113
Alaska Air
ALK
$5.61B
$357K 0.31%
6,125
+3,350
+121% +$231K
ROL icon
114
Rollins
ROL
$18B
$354K 0.3%
27,225
-19,688
-42% -$242K
EPD icon
115
Enterprise Products Partners
EPD
$82.5B
$353K 0.3%
+12,055
New +$324K
KMI icon
116
Kinder Morgan
KMI
$69.2B
$351K 0.3%
18,742
-30
-0.2% -$535
AGN
117
DELISTED
Allergan plc
AGN
$341K 0.29%
+1,475
New +$340K
WBA
118
DELISTED
Walgreens Boots Alliance
WBA
$339K 0.29%
4,075
PKG icon
119
Packaging Corp of America
PKG
$22.7B
$330K 0.28%
4,925
-900
-15% -$58.8K
TOL icon
120
Toll Brothers
TOL
$14.3B
$328K 0.28%
12,175
-1,225
-9% -$34.4K
EXPE icon
121
Expedia Group
EXPE
$37.1B
$324K 0.28%
3,050
+900
+42% +$97.8K
C icon
122
Citigroup
C
$226B
$314K 0.27%
7,400
-900
-11% -$39.8K
STT.PRC.CL
123
DELISTED
STATE STREET CORPORATION Depositary Shares, each representing a 1/4,000th ownership interest in a sh
STT.PRC.CL
$314K 0.27%
11,900
TGT icon
124
Target
TGT
$67.2B
$307K 0.26%
4,400
-350
-7% -$26.1K
AMZN icon
125
Amazon
AMZN
$2.99T
$301K 0.26%
8,400
-400
-5% -$13.5K

Similar funds

New England Research & Management's Q2 2016 Portfolio in Review

As of Q2 2016, New England Research & Management held 184 positions worth $116M, down 1.2% from $118M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q2 2016 filing shows 25 new, 26 increased, 81 reduced and 25 closed positions. Its largest new stake was AstraZeneca: 12,875 shares worth $777K. The largest sale was Martin Marietta Materials, an estimated $829K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Staples.

  • New England Research & Management's largest Q2 2016 buy was AstraZeneca: 12,875 shares worth $777K.
  • New England Research & Management added most to Valero Energy in Q2 2016, an estimated $1.1M increase.
  • New England Research & Management's biggest Q2 2016 reduction was Bristol-Myers Squibb, cutting an estimated $664K.
  • New England Research & Management fully exited Martin Marietta Materials in Q2 2016, selling an estimated $829K.
  • New England Research & Management's ten largest holdings make up 24% of its $116M portfolio in Q2 2016.
  • New England Research & Management opened 25 new positions and closed 25 in Q2 2016.
  • New England Research & Management's portfolio value fell 1.2% quarter-over-quarter to $116M.

Based on New England Research & Management's 13F filing for Q2 2016, filed 5 Jul 2016.